引用本文:
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 4868次   下载 3054 本文二维码信息
码上扫一扫!
分享到: 微信 更多
动脉粥样硬化患者NLRP3炎性体分子表达及临床意义
陈国伟, 吴小兰, 陈冬梅, 沈荣兴, 陈建忠
桐乡市第二人民医院检验科
摘要:
目的研究动脉粥样硬化患者含热蛋白结构域3的核苷酸结合寡聚化样受体(NLRP3)炎性体相关分子表达与疾病之间的关系。方法采用酶联免疫吸附(ELISA)法测定40例动脉粥样硬化患者(实验组)和40例健康志愿者(对照组)血浆中IL-1β、IL-18和IL-37的含量,采用定量聚合酶链反应(PCR)检测两组单核细胞来源的巨噬细胞(MDM)表达NLPR3、凋亡相关斑点样蛋白(ASC)和IL-1βmRNA水平,采用ELISA技术检测胆固醇结晶诱导MDM分泌IL-1β和TNF-琢的水平。结果动脉粥样硬化患者血浆中的IL-1β和IL-18含量均显著高于对照组,差异均有统计学意义(均P<0.05);IL-37高于对照组,但无统计学差异(P>0.05);动脉粥样硬化患者MDM中NLPR3、ASC和IL-1βmRNA表达均显著高于对照组,差异均有统计学意义(均P<0.05);且经胆固醇结晶刺激后IL-1β、TNF-琢的分泌水平显著高于对照组,差异均有统计学意义(均P<0.05)。结论NLRP3炎性体活化可能参与动脉粥样硬化的炎症反应过程。
关键词:  白细胞介素 -1β 动脉粥样硬化 含热蛋白结构域 3 的核苷酸结合寡聚化样受体 炎性体
DOI:10.12056/j.issn.1006-2785.2018.40.11.2017-1247
分类号:
基金项目:浙江省自然科学基金项目(LY14H100003);桐乡市科技局项目(201502037)
Expression of NLRP3 inflammasome pathway molecules in patients with atherosclerosis
Tongxiang Second People's Hospital
Abstract:
Objective To investigate the expression of NLRP3 inflammasome related molecules in patients with atherosclerosis and its significance. Methods The plasma levels of IL-1β, IL-18 and IL-37 in 40 patients with atherosclerosis and 40 healthy controls were detected with ELISA. Expression of NLRP3, ASC and IL-1 β mRNA in monocytes derived macrophages (MDM) were detected by real time RT-PCR. The IL-1β and TNF- α levels in MDM after stimulation with cholesterol crystal were also analyzed with ELISA. Results IL-1β and IL-18 levels in atherosclerotic patients were significantly higher than those in normal controls (P <0.05), while there was no significant difference in IL-37 level between patients and controls (P >0.05). Expression of NLRP3, ASC and IL-1 β mRNA in MDM and IL-1 β、TNF- α secreted by MDM of atherosclerotic patients were significantly higher than those of controls (P <0.05). Conclusion The NLRP3 inflammasome pathway may play an important role in the patients with atherosclerosis.
Key words:  Interleukin-1beta Atherosclerosis NLRP3 protein Inflammasomes,